Philip Komarnitsky
Chief Medical Officer at Nested Therapeutics
Brookline, Massachusetts, United States
Find your path to Philip
343 people in our graph can introduce you to Philip.
Sign up to see every warm intro you have to Philip
- Paths you didn't know you had: your email and LinkedIn already hold routes to Philip. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Experience
- Nested TherapeuticsChief Medical Officercurrent2022 — presentCambridge, Massachusetts, United States
- Sumitomo Dainippon Pharma OncologyVice President, Head of Translational Medicine and Early Development2020 — 2022Cambridge, Massachusetts, United States
- AbbVieGroup Medical Director2018 — 2020Cambridge, United States
- AbbVieSenior Medical Director, Oncology Clinical Development2015 — 2018Cambridge, MA, USA
- AbbVieMedical Director2014 — 2015Cambridge, Massachusetts, United States
- AVEO OncologyMedical Director2012 — 2013Cambridge, MA
- EMD SeronoMedical Director, Oncology2009 — 2012
- Ziopharm Oncology IncAssociate Medical Director & Senior Director Project Management2008 — 2009
- Ziopharm Oncology IncDirector Technology Operations2006 — 2008
- Ziopharm Oncology IncAssociate Director Technology Operations2006
- Putnam AssociatesHelthcare strategy2005 — 2006
- Millennium PharmaceuticalsOncology drug discovery2000 — 2003
- Harvard Medical SchoolFellow1997 — 2000
Skills & more
Clinical1Oncology18Clinical Development21Biochemistry7Biotechnology10Clinical Research7Biologics1Biomarkers2Lifesciences5Medical Devices1Clinical Trials4
Languages English · Russian
From Philip's professional profile.
Frequently asked questions
- Who is Philip Komarnitsky?
- Chief Medical Officer at Nested Therapeutics
- Where did Philip Komarnitsky go to school?
- Philip Komarnitsky studied at MIT Sloan School of Management (MBA); University of New Hampshire (PhD, Biochemistry); The Russian State Medical University (MD, medicine).
Same school
Also attended MIT Sloan School of Management1,028
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOla SmebyInvestor at Investinor
+ 1,022 more
Also attended University of New Hampshire104
Jessica DowdInvestor at OpenView Venture PartnersRosemary SullivanOperations Manager at RET VenturesAndrew BrochuController at Castle Island VenturesBryce BlairAdvisory Board at Navitas CapitalChris StoneInvestor at EPIC VENTURESMitch JuneauFellow, Materials at Prime Movers Lab
+ 98 more
Shared employers
Also worked at AbbVie76
Nick GasbarroChief of Staff at QED InvestorsCharles White, Ph.D.Principal at Illumina VenturesLaura QuockCBO-in-Residence at Versant VenturesManik PasrichaVice President at Titan CapitalJennifer SmoterChief Communications & Governance Officer at Takeda VenturesTakehiko SawabeDirector at Beyond Next Ventures
+ 70 more
Also worked at AVEO Oncology6
Also worked at EMD Serono30
Chris RobinsonInvestor at Third Rock VenturesRoel BulthuisInvestor at SynconaYvonne YamanakaPartner at venBio PartnersParis PanayiotopoulosSenior Managing Director at Blackstone Life SciencesKen MacLeodPartner at Rosetta Capital Ltd.Alicia Irurzun-LafittePartner at UCB Ventures
+ 24 more
Also worked at Putnam Associates19
Elena VibochManaging Director at General CatalystKathryn Taylor ReddyPrincipal at .406 VenturesTara SullivanPrincipal at Flare Capital PartnersJake BauerVenture Partner at ARCH Venture PartnersCharles White, Ph.D.Principal at Illumina VenturesPeter EmighFounder & President, Savoy Life at Red Cell Incubation
+ 13 more








































